The US bioresorbable polymers market revenue has grown robustly from USD 1,150 Million in 2020 to USD 1,480 Million by 2025. Projections indicate a strong upward trajectory, with revenue expected to reach approximately USD 4,200 Million by 2035. This steady growth is attributed to increasing applications in emerging medical fields, higher healthcare spending, and the continuous introduction of advanced polymer solutions that address evolving clinical needs.
Read More - https://bussinessinsights.com/research-report/us-bioresorbable-polymers-market
Orthopedic surgery remains the largest application segment for US bioresorbable polymers in 2025, primarily due to the rising prevalence of bone and joint disorders and the increasing need for bioresorbable implants. Drug delivery follows as a major application, as innovative polymer-based delivery systems see rapid healthcare adoption. Dentistry, cardiovascular, wound management, and other applications also contribute, showing a well-rounded diversification of bioresorbable polymer usage across US medical fields.
Request Free Sample- https://bussinessinsights.com/request/chemical-and-material/us-bioresorbable-polymers-market
Who are the key players in US Bioresorbable Polymers Market industry?
The top 5 players in the US Bioresorbable Polymers Market are Evonik Industries, Corbion N.V., Ashland Global Holdings Inc., Foster Corporation, and Poly-Med Inc. These companies focus on innovation, strong R&D efforts, and robust manufacturing capabilities to offer high-quality bioresorbable polymers for medical and pharmaceutical applications.
What is the US Bioresorbable Polymers Market growth?
The US Bioresorbable Polymers Market has shown steady growth, driven by rising demand for minimally invasive surgeries and advanced drug delivery. In 2023, Evonik Industries reported increased polymer sales due to the healthcare sector's adoption of resorbable materials in orthopedic devices and sutures.
Which segment accounted for the largest US Bioresorbable Polymers Market share?
Orthopedic devices held the largest market share in the US Bioresorbable Polymers Market. This dominance is attributed to the widespread use of these polymers in implants, screws, pins, and plates, due to their ability to safely degrade inside the body, thereby eliminating the need for surgical removal.
Thanks & Regards,
Manisha C
sales [at] bussinessinsights.com